Diagnostic Center | February 28, 2024
New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions with food allergies
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
_256_275.jpg)